It is a first-in-class triple hormone receptor agonist, designed as a single molecule that simultaneously activates three distinct receptors: glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon (GCG)
Lencer (Boston Childrens Hospital, Harvard Medical School and Harvard Digestive Diseases center, United States) were cultured in MCDB 131 medium (Gibco) supplemented with 10% (v/v) heat-inactivated fetal bovine serum (FBS) (Gibco), 2 mM l-glutamine (Gibco), 25 g/mL streptomycin (Gibco), 25 U/mL penicillin (Gibco), 10 ng/mL recombinant mouse epidermal growth factor (Gibco), and 1 g/mL hydrocortisone (Sigma-Aldrich), at 37 C in a humidified atmosphere of 5% CO 2
While they may not always occur, they are more likely to do so when first restarting a GLP-1 or when increasing the dose
Does either research pen require preparation
26 This marked a significant advancement in obesity treatment research, especially in combining multiple drug targets
